BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 24524821)

  • 1. Can calcium signaling be harnessed for cancer immunotherapy?
    Rooke R
    Biochim Biophys Acta; 2014 Oct; 1843(10):2334-40. PubMed ID: 24524821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal interaction molecules as important therapeutic targets in diseases with dysregulated calcium flux.
    Mukherjee S; Brooks WH
    Biochim Biophys Acta; 2014 Oct; 1843(10):2307-14. PubMed ID: 24681268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New functions of mitochondria associated membranes in cellular signaling.
    van Vliet AR; Verfaillie T; Agostinis P
    Biochim Biophys Acta; 2014 Oct; 1843(10):2253-62. PubMed ID: 24642268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
    Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
    Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer vaccine development: on the way to break immune tolerance to malignant cells.
    Mocellin S; Rossi CR; Nitti D
    Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing immune responses to tumor-associated antigens.
    Higgins JP; Bernstein MB; Hodge JW
    Cancer Biol Ther; 2009 Aug; 8(15):1440-9. PubMed ID: 19556848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
    Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
    Mapara MY; Sykes M
    J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
    Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
    Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCa and Ca(2+) channels: the complex thought.
    Guéguinou M; Chantôme A; Fromont G; Bougnoux P; Vandier C; Potier-Cartereau M
    Biochim Biophys Acta; 2014 Oct; 1843(10):2322-33. PubMed ID: 24613282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of novel store-operated calcium entry effectors.
    Djillani A; Nüße O; Dellis O
    Biochim Biophys Acta; 2014 Oct; 1843(10):2341-7. PubMed ID: 24657813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual face of connexin-based astroglial Ca(2+) communication: a key player in brain physiology and a prime target in pathology.
    De Bock M; Decrock E; Wang N; Bol M; Vinken M; Bultynck G; Leybaert L
    Biochim Biophys Acta; 2014 Oct; 1843(10):2211-32. PubMed ID: 24768716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 regulation of the inositol 1,4,5-trisphosphate receptor and calcium signaling in normal and malignant lymphocytes: potential new target for cancer treatment.
    Greenberg EF; Lavik AR; Distelhorst CW
    Biochim Biophys Acta; 2014 Oct; 1843(10):2205-10. PubMed ID: 24642270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse immunoediting: When immunity is edited by antigen.
    Merlo A; Dalla Santa S; Dolcetti R; Zanovello P; Rosato A
    Immunol Lett; 2016 Jul; 175():16-20. PubMed ID: 27131431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.
    Ivanova H; Vervliet T; Missiaen L; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2164-83. PubMed ID: 24642269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.